- Home
- CVM vs BEAT Comparison
CVM vs BEAT Comparison
Compare CVM & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- BEAT
- Stock Information
- Founded
- CVM 1983
- BEAT 2015
- Country
- CVM United States
- BEAT United States
- Employees
- CVM 44
- BEAT N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- CVM Health Care
- BEAT Technology
- Exchange
- CVM Nasdaq
- BEAT Nasdaq
- Market Cap
- CVM 60.9M
- BEAT 58.0M
- IPO Year
- CVM 1987
- BEAT 2021
- Fundamental
- Price
- CVM $9.12
- BEAT $1.69
- Analyst Decision
- CVM
- BEAT Buy
- Analyst Count
- CVM 0
- BEAT 1
- Target Price
- CVM N/A
- BEAT $8.00
- AVG Volume (30 Days)
- CVM 82.9K
- BEAT 81.2K
- Earning Date
- CVM 08-14-2025
- BEAT 11-06-2025
- Dividend Yield
- CVM N/A
- BEAT N/A
- EPS Growth
- CVM N/A
- BEAT N/A
- EPS
- CVM N/A
- BEAT N/A
- Revenue
- CVM N/A
- BEAT N/A
- Revenue This Year
- CVM N/A
- BEAT N/A
- Revenue Next Year
- CVM N/A
- BEAT $19.35
- P/E Ratio
- CVM N/A
- BEAT N/A
- Revenue Growth
- CVM N/A
- BEAT N/A
- 52 Week Low
- CVM $1.98
- BEAT $0.91
- 52 Week High
- CVM $32.70
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- CVM 46.34
- BEAT 55.00
- Support Level
- CVM $8.61
- BEAT $1.66
- Resistance Level
- CVM $10.24
- BEAT $1.84
- Average True Range (ATR)
- CVM 0.68
- BEAT 0.13
- MACD
- CVM -0.13
- BEAT -0.02
- Stochastic Oscillator
- CVM 20.50
- BEAT 24.69
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.